Literature DB >> 28572073

Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia.

Jiawei Zeng1, Lidan Zhang2, Min Gao3, Jingjing Wu1, Haiyan Wu1, Jie Chen1, Xiao Chen1, Wen Tang4.   

Abstract

The successful use of tigecycline in a 12-month old liver transplant recipient with extensively drug-resistant Acinetobacter baumannii bacteremia is presented. Tigecycline serum concentrations were monitored to help improve antibiotic efficacy and minimize side effects. A literature review identified 11 additional pediatric cases of A. baumannii infection treated with tigecycline since 2011. Tigecycline treatment should be considered in children with extensively drug-resistant bacterial infections.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Tigecycline; XDR Acinetobacter baumannii; bacteremia; pediatric

Mesh:

Substances:

Year:  2017        PMID: 28572073     DOI: 10.1016/j.ijid.2017.05.013

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  5 in total

1.  Antibiogram of Urinary Tract Infections and Sepsis among Infants in Neonatal Intensive Care Unit.

Authors:  Abdulrahman S Bazaid; Abdu Aldarhami; Hattan Gattan; Heba Barnawi; Husam Qanash; Ghaida Alsaif; Bandar Alharbi; Abdulaziz Alrashidi; Essam Hassan Eldrehmy
Journal:  Children (Basel)       Date:  2022-04-28

2.  Tigecycline application in a 3-month-old infant with multiple drug resistant Klebsiella pneumonia: a case report.

Authors:  Cheng Peng; Xiaofeng Wang; Jiangwei Zhang; Yi Jiang; Xinlin Hou
Journal:  Gut Pathog       Date:  2018-06-22       Impact factor: 4.181

3.  Tigecycline treatment in a liver transplant infant with carbapenem-resistant Escherichia coli infection: Case report.

Authors:  Mei Yang; Hengmiao Gao; Xiaoling Wang; Suyun Qian
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

4.  Tigecycline-Induced Tooth Discoloration in Children Younger than Eight Years.

Authors:  Zhengyi Zhu; Qi Yu; Ganggang Qi; Jufei Yang; Yinghua Ni; Wenhua Ruan; Luo Fang
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

5.  Evaluating the performance characteristics of different antimicrobial susceptibility testing methodologies for testing susceptibility of gram-negative bacteria to tigecycline.

Authors:  Sima Babaei; Mehri Haeili
Journal:  BMC Infect Dis       Date:  2021-07-27       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.